BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16700748)

  • 1. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with burning mouth syndrome.
    Boras VV; Brailo V; Lukac J; Kordić D; Blazić-Potocki Z
    Oral Dis; 2006 May; 12(3):353-5. PubMed ID: 16700748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary levels of IL-1beta, IL-6, IL-8, and TNF-alpha in patients with burning mouth syndrome.
    Suh KI; Kim YK; Kho HS
    Arch Oral Biol; 2009 Sep; 54(9):797-802. PubMed ID: 19555923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burning mouth syndrome and saliva: detection of salivary trace elements and cytokines.
    Pekiner FN; Gümrü B; Demirel GY; Ozbayrak S
    J Oral Pathol Med; 2009 Mar; 38(3):269-75. PubMed ID: 19141055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with recurrent aphthous ulceration.
    Boras VV; Lukac J; Brailo V; Picek P; Kordić D; Zilić IA
    J Oral Pathol Med; 2006 Apr; 35(4):241-3. PubMed ID: 16519772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary interleukin-6 and tumor necrosis factor alpha in patients with drug-induced xerostomia.
    Vucićević Boras V; Brailo V; Lukac J; Kordić D; Picek P; Blazic-Potocki Z
    Oral Dis; 2006 Sep; 12(5):509-11. PubMed ID: 16910924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of salivary interleukin 6 and tumor necrosis factor alpha in patients with oral leukoplakia.
    Brailo V; Vucićević-Boras V; Cekić-Arambasin A; Alajbeg IZ; Milenović A; Lukac J
    Oral Oncol; 2006 Apr; 42(4):370-3. PubMed ID: 16324876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burning mouth syndrome: a therapeutic approach involving mechanical salivary stimulation.
    de Souza FT; Amaral TM; dos Santos TP; Abdo EN; Aguiar MC; Teixeira AL; Kummer AM; Abreu MH; Silva TA
    Headache; 2012 Jun; 52(6):1026-34. PubMed ID: 22084903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cytokine and T regulatory cell levels in patients with burning mouth syndrome.
    Pekiner FN; Demirel GY; Gümrü B; Ozbayrak S
    J Oral Pathol Med; 2008 Oct; 37(9):528-34. PubMed ID: 18624934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of total IgE in unspecified burning oral symptoms. Serum and salivary comparative levels in a case-control study].
    Campisi G; Di Liberto C
    Minerva Stomatol; 2003; 52(7-8):381-91. PubMed ID: 14608259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary concentration of TNFalpha, IL1 alpha, IL6, and IL8 in oral squamous cell carcinoma.
    SahebJamee M; Eslami M; AtarbashiMoghadam F; Sarafnejad A
    Med Oral Patol Oral Cir Bucal; 2008 May; 13(5):E292-5. PubMed ID: 18449112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burning mouth syndrome (BMS): sialometric and sialochemical analysis and salivary protein profile.
    de Moura SA; de Sousa JM; Lima DF; Negreiros AN; Silva Fde V; da Costa LJ
    Gerodontology; 2007 Sep; 24(3):173-6. PubMed ID: 17696895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral burning symptoms and burning mouth syndrome-significance of different variables in 150 patients.
    Brailo V; Vuéiaeeviae-Boras V; Alajbeg IZ; Alajbeg I; Lukenda J; Aeurkoviae M
    Med Oral Patol Oral Cir Bucal; 2006 May; 11(3):E252-5. PubMed ID: 16648763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma.
    Rhodus NL; Ho V; Miller CS; Myers S; Ondrey F
    Cancer Detect Prev; 2005; 29(1):42-5. PubMed ID: 15734216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety and salivary cortisol levels in patients with burning mouth syndrome: case-control study.
    Amenábar JM; Pawlowski J; Hilgert JB; Hugo FN; Bandeira D; Lhüller F; Lopes de Souza MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):460-5. PubMed ID: 18329582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study.
    Borelli V; Marchioli A; Di Taranto R; Romano M; Chiandussi S; Di Lenarda R; Biasotto M; Zabucchi G
    Oral Dis; 2010 May; 16(4):365-74. PubMed ID: 20233324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.
    Yoon KC; Jeong IY; Park YG; Yang SY
    Cornea; 2007 May; 26(4):431-7. PubMed ID: 17457192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
    Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
    Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlations among mood disorder, serum interleukin-2 and interleukin-6 in patients with burning mouth syndrome].
    Xia J; Lin M; Jin Z
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Oct; 21(5):377-8. PubMed ID: 14650995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burning mouth syndrome and personality profiles.
    Merigo E; Manfredi M; Zanetti MR; Miazza D; Pedrazzi G; Vescovi P
    Minerva Stomatol; 2007 Apr; 56(4):159-67. PubMed ID: 17452954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory cytokine levels in saliva before and after treatment of (erosive) oral lichen planus with dexamethasone.
    Rhodus NL; Cheng B; Bowles W; Myers S; Miller L; Ondrey F
    Oral Dis; 2006 Mar; 12(2):112-6. PubMed ID: 16476030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.